Health ❯ Healthcare ❯ Public Health

Vaccines

COVID-19 Vaccines Vaccine Safety Autism Influenza Vaccines Vaccine Skepticism mRNA Vaccines Shingles Vaccine COVID-19 Thimerosal Vaccine Advisory Committees

FDA Expands GSK’s Arexvy to High-Risk Adults 18–49, Completing Trio of RSV Vaccines for Younger At‑Risk Group

U.S. vaccine advisers have not yet recommended immunization for this population.

FDA Advisers Back 2026–27 Flu Shot Overhaul to Target Dominant H3N2 Variant

AMA and Vaccine Integrity Project Launch Independent Vaccine Evidence Reviews for 2026–27 Season

Basque Leader Pradales Apologizes for Expired Vaccines, Pledges to Clarify Responsibility

Kennedy Appoints Two OB-GYNs to CDC Vaccine Panel, Extending Overhaul of ACIP

Shingles Vaccine Linked to Lower Dementia Risk and Fewer Deaths in New Analysis

JAMA Study Finds 2024–2025 COVID Vaccines Reduce Severe Illness, With Protection Waning by 20 Weeks

HPV Vaccine Delivers Community-Wide Protection in 17-Year Study

Cochrane Review Finds RSV Vaccines Protect Older Adults and Infants Without Raising Serious Risks

States Restore Broad COVID-19 Shot Access as Pharmacies Roll Out Patchwork Policies

States Broaden Access to Updated COVID-19 Shots as Federal Limits Create Patchwork

JAMA Study Finds Vaccine Panel Conflicts Minimal Before Kennedy’s Overhaul

HHS Revives Childhood Vaccine Safety Task Force, Names Bhattacharya Chair

FDA Weighs Ending Pfizer COVID-19 Authorization for Children Under 5

HHS Bars Major Medical Societies From CDC Vaccine Advisory Panel

ICMR Invites Expressions of Interest for AdFalciVax Technology Transfer

Kennedy’s Handpicked Vaccine Panel Bans Thimerosal Flu Shots, Backs New RSV Antibody

FDA Expands Myocarditis and Pericarditis Warnings on mRNA COVID-19 Vaccines

Kennedy’s New Vaccine Panel to Vote on Thimerosal, RSV Shots and MMRV Use

FDA Approves Moderna’s mNEXSPIKE for Seniors and High-Risk Adults as CDC Drops Recommendations for Healthy Children and Pregnant Women